Phytanic acid-d3
Based on 1 Customer Validation
Phytanic acid-d3 is the deuterium labeled Phytanic acid. Phytanic acid is an endogenous metabolite present in Blood that can be used for the research of Zellweger Syndrome, Alpha Methylacyl CoA Racemase Deficiency, Rhizomelic Chondrodysplasia Punctata and Infantile Refsum Disease.
The product specifications provided below refer solely to the active content of Phytanic acid-d3.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98.95%
- No. CAS: 1383920-40-8
- Fòrmula: C20H37D3O2
- Peso molecular:315.55
-
Almacenamiento:
Solution, -20°C, 2 years
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-N0830S2
Palmitic acid-d31Stable Isotope -
HY-N0729S2
Linoleic acid-13C18Stable Isotope -
HY-121883S4
Lignoceric acid-d4-2Stable Isotope -
HY-109590S
Arachidonic acid-d8Stable Isotope -
HY-N2041S
Myristic acid-d27Stable Isotope -
HY-N0830S9
Palmitic acid-13CStable Isotope -
HY-Y0366S1
Lauric acid-d23Stable Isotope -
HY-N0729S
Linoleic acid-d4Stable Isotope -
HY-N2041S2
Myristic acid-13CStable Isotope -
HY-N0830S3
Palmitic acid-1-13CStable Isotope
Ver todos los productos específicos de isoformas Endogenous Metabolite
More
Actividad biológica
Descripciòn
The product specifications provided below refer solely to the active content of Phytanic acid-d3.
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Aplicación
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
No. CAS 1383920-40-8
-
Unlabeled CAS 14721-66-5
-
Appearance Liquid
-
Peso molecular 315.55
-
Fòrmula C20H37D3O2
-
Color Colorless to light yellow
-
SMILES
CC(C)CCCC(C)CCCC(C)CCCC(C([2H])([2H])[2H])CC(O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Solution, -20°C, 2 years
Pureza y Documentación
-
Ficha de datos (269 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
[2]. Budden SS, et al. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids, and pipecolic acidemia: studies in four children. J Pediatr. 1986 Jan;108(1):33-9. [Content Brief]
[3]. McLean BN, et al. A new defect of peroxisomal function involving pristanic acid: a case report. J Neurol Neurosurg Psychiatry. 2002 Mar72(3):396-9. [Content Brief]
[4]. Baumgartner MR, et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol. 1998 Nov44(5):720-30. [Content Brief]
[5]. Poll-The BT, et al. Infantile Refsum's disease: biochemical findings suggesting multiple peroxisomal dysfunction. J Inherit Metab Dis. 19869(2):169-74. [Content Brief]
[6]. Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug39(35):5709-5720. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Phytanic acid-d3 Related Classifications
HY-113067S Related Classifications
Powered by Bioz